One of the crucial steps during drug development and manufacturing is to ensure safety from viruses. Even trace amounts of viruses can pose serious health risks. Viral filtration studies help assess and remove any risk of viral contamination. These studies are conducted at various stages - on raw materials, in-process samples, and finished drug products. They provide vital data to regulatory agencies on the efficacy of viral filtration procedures adopted by pharmaceutical companies.
Raw Material Testing
All biological raw materials used in drug manufacturing like cell lines, serum, and enzymes are first screened for presence of viruses. Cell banks and seed lots are tested to check for any adventitious viruses. Modern techniques like virus spiking, PCR, and microarrays help detect even unknown and emerging viruses. Any raw material batch found to contain viruses is rejected. Strict sourcing from qualified vendors also helps maintain high-quality raw materials free from viral contamination.
In-Process Monitoring
Various in-process steps during drug production like filtration, chromatography, and viral inactivation/removal methods are validated for their viral filtration capacity. Representative samples are taken from these processes and spike-tested with model viruses. The log reduction value achieved helps evaluate the effectiveness of each viral filtration step. Any step found ineffective is further optimized till satisfactory viral filtration is achieved and documented. This continuous monitoring ensures maximum safety is built into the manufacturing process.
Finished Product Testing
Besides characterization and release testing, finished drug batches also undergo stringent viral safety testing. They are tested for presence of adventitious viruses by inoculation on sensitive cell lines. Absence of viral growth after multiple passages confirms drug safety. Some products may also be tested by PCR or other modern viral detection techniques. Only batches that clear all safety parameters as per regulatory guidelines are approved and released for patient use. This final check validates the entire viral risk mitigation strategy adopted during development and manufacture.
Data Collection And Reporting
All Viral Clearance study data right from raw material qualification to finished product release is systematically captured and reported. Log reduction values achieved at each step, test method details and validation parameters, identification of any viral contaminants - every finding is thoroughly documented. Comprehensive reports are prepared for regulatory submission. They demonstrate scientifically the levels of process robustness and quality assurance implemented to safeguard patients. Regulators rely on this data for their final evaluation and approval of the manufacturing process.
Continuous Improvement
Even after product approval and commercial manufacturing, the commitment to patient safety continues. Ongoing viral filtration studies are conducted using an enhanced potency approach to check for any previously unknown or emerging viruses. New detection technologies are also evaluated to further strengthen safety. Feedback and experience from commercial manufacturing are reviewed to identify additional optimization opportunities. An environment of continuous learning and upgrading helps ensure highest assurance of a virus-safe drug supply for patients world over.
Viral Clearance studies are a critical governing process in pharmaceutical development and production. They aim to scientifically verify and demonstrate removal of all viral risks inherent across the product life cycle, from raw materials to patient usage. When conducted systematically using state-of-the-art techniques and with an improvement mindset, these studies provide robust assurance of a manufacturing process capable of delivering safely to patients.
Get more insights on this topic: https://www.trendingwebwire.com/understanding-viral-clearance-in-biopharmaceutical-manufacturing/
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Comments
0 comment